Reproductive Endocrinology Ovulation Physiology
RRM Academy Synopsis
Earlier failed ovulation induction did not change IUI results in PCOS
A cohort study of 1,086 women with polycystic ovary syndrome (PCOS, also called PMOS) at one Shanghai hospital found that earlier failed ovulation induction did not change pregnancy rates after IUI. About 2 out of 10 cycles ended in a pregnancy in each group.
Key Findings
- The study followed 1,086 women with PCOS under age 40 through 1,868 IUI cycles between January 2007 and July 2021. Every cycle used the same ovarian stimulation combination.
- Clinical pregnancy per cycle was 21.14% (141/667) with no previous ovulation induction cycles, 21.95% (90/410) with 1-2, and 23.64% (187/791) with 3 or more (p=0.507).
- Live birth per cycle was 16.64% (95/571), 18.06% (65/360) and 18.68% (139/744) in the same three groups (p=0.627).
- Approximately 98% of pregnancies occurred in the first 3 cycles of IUI.
- Ectopic pregnancy differed between groups: 1.46% (6/410) with 1-2 previous cycles, 0.60% (4/667) with none, and 0.25% (2/791) with 3 or more (p=0.044).
Interpretation
The study is a single-center retrospective cohort. It reports outcomes after IUI and has no timed-intercourse comparison group, because the center did not hold those data. Couples with blocked tubes or severe sperm abnormalities were excluded. Live birth counted only cycles completed before December 2020. The authors note that earlier stimulation drugs were not recorded in detail, and that their pregnancy totals may run low because patients who left for IVF/ICSI early were not captured. The authors strongly recommend three IUI attempts for women with PCOS before IVF/ICSI.
RRM Context
PCOS has metabolic, hormonal and reproductive features. The paper tracks pregnancy after IUI and does not examine the causes of each woman's missed ovulation. Restorative reproductive medicine asks why ovulation is disrupted, including the insulin resistance the paper lists. IUI and IVF help conception along while that cause remains.
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common reasons for infertility. The consensus of the treatment of infertile women with PCOS is ovulation induction (OI) for six to nine attempts beforein vitrofertilization (IVF)/intracytoplasmic sperm injection (ICSI). Nowadays, more attention was paid to a rising, noninvasive treatment, intrauterine insemination (IUI), as some experts claimed IUI could benefit PCOS patients with infertility. Our study means to investigate the outcomes of IUI for PCOS patients and if patients’ previous OI cycles can be a predictive factor for IUI outcomes.
A total of 1,086 PCOS patients was included and 1,868 IUI cycles were performed between January 2007 and July 2021 in the department of assisted reproduction in Shanghai Ninth People’s Hospital. All included patients underwent IUI treatments with letrozole+human menopausal gonadotropin (LE+hMG) for ovarian stimulation.
The pregnancy outcomes were not associated with the attempts of failed OI cycles previously. Specifically, the clinical pregnancy rate was 21.14% for PCOS patients without previous OI cycles, 21.95% for PCOS patients with 1-2 previous OI cycles and 23.64% for PCOS patients with 3 or more previous OI cycles (p=0.507). The corresponding live birth rate was 16.64%, 18.06%, and 18.68%, respectively, of which the difference was not statistically significant (p=0.627). The cumulative rate per patient was 38.59% for clinical pregnancy and 31.03% for live birth, and approximately 98% of the pregnancies occurred in the first 3 cycles of IUI.
PCOS women with different attempts of OI cycles had similar pregnancy outcomes after IUI, thus a history of repeated failures of OI treatments was not a predictive factor for the pregnancy outcomes in IUI cycles. Most pregnancies occurred in the first three cycles of IUI, so we strongly recommended three attempts of IUI for PCOS women before they switched to IVF/ICSI. Generally, IUI might be an assist for infertile women with PCOS before IVF/ICSI and might accelerate pregnancy for target women without invasive manipulations.


